Results 161 to 170 of about 1,682,836 (306)

Biomaterial‐Integrated Electroporation for Therapeutic Delivery: From Gene Editing to Tumor Ablation and Immune Modulation

Small, EarlyView.
Biomaterial‐integrated electroporation establishes a programmable therapeutic interface that coordinates electric‐field modulation, transient or irreversible membrane permeabilization, cargo stabilization, and immune remodeling. This Review highlights how nanocarriers, hydrogels, and bioelectronic interfaces expand electroporation from conventional ...
Binbin Ji, Zhuozhuo Wu, Yuyue Jiang, Xiaoyu Liu, Jingfeng Li, Fengkuo Xu, Chaojie Li, Qungang Shan, Ziyin Wang, Junhao Wang, Wei Huang, Yaping Zhuang, Wenguo Cui, Zhongmin Wang   +13 more
wiley   +1 more source

Antiviral efficacy of LNP-delivered IFN-α14-ApoAI mRNA for chronic hepatitis B. [PDF]

J Virus Erad
Yang Q, Li Q, Cao J, Zhao C, Lu M, Sun S, Chen M, Chen C, Huang Y, Tao S, Chen L.   +10 more
europepmc   +1 more source

Long‐acting monoclonal antibodies and the evolving landscape of infant respiratory syncytial virus prevention

Pediatric Investigation, EarlyView.
Ran Wang, Bahaa Abu‐Raya, Hala Obeid, Zhengde Xie   +3 more
wiley   +1 more source

Self‐Organized Vascularized Human Liver Spheroids: Serum‐Free Culture Conditions and Use as Tissue Building Blocks

Small, EarlyView.
This approach addresses a major challenge in tissue engineering: creating larger, vascularized tissues. Microvascular networks in liver spheroids are developed through self‐organization mediated by mesenchymal stem cells. These spheroids are maintained in serum‐reduced or serum‐free medium and serve as building blocks to form planar tissue layers ...
Alina Filatova, Olivera Valentirović Dann, Jennifer B. Schwarzkopf, Tengku I. Maulana, Jamina S. Gerhardus, Leon Kaysan, Katja Meier, Andreas Blaeser, Beate K. Straub, Holger Gerhardt, Ulrike A. Nuber   +10 more
wiley   +1 more source

Blood protein biomarkers in hepatocellular carcinoma: progress and challenges. [PDF]

PeerJ
Zhang L, Zhang M, Bao Y, Yang J, Luo T, Zhang Y, Wang Y, Liu P, Guo X.   +8 more
europepmc   +1 more source

Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection

Hepatology, 1995
R. Hoffmann, H. Diepolder, R. Zachoval, F. Zwiebel, M. Jung, S. Scholz, H. Nitschko, G. Riethmüller, G. Pape   +8 more
semanticscholar   +1 more source

Applications of chitosan derivatives as adjuvants for nanoparticle‐based vaccines: A comprehensive review

Smart Molecules, EarlyView.
This review highlights how chitosan derivatives enhance nanoparticle‐based vaccines through superior stability, mucoadhesion, and immune modulation. By triggering robust mucosal, humoral, and cellular responses, these biocompatible polymers serve as a transformative platform for next‐generation immunotherapeutics and safe and effective vaccine delivery
Sayantani Dasgupta, Susanta Paul, Swarupananda Mukherjee, Nilanjan Sarkar, Arvind Kumar, Amrita Chakraborty, Anannya Bose, Atanu Hazra, Mainak Chakraborty   +8 more
wiley   +1 more source

Secondary Syphilis With Concomitant Bullous Pemphigoid: A Case Report. [PDF]

Case Rep Dermatol Med
Rijal S, Sitaula D, Gyawalee M, Paudel V, Kafle M, Khadka A, Magar ST, Paudel B, Jha A, Amatya A, Kayastha B.   +10 more
europepmc   +1 more source

Risk Factors for Cutaneous Immune‐Related Adverse Events in the Japanese Population: A Retrospective Single‐Center Cohort Study

The Journal of Dermatology, EarlyView.
ABSTRACT Immune checkpoint inhibitor (ICI)‐driven alterations in the immune system can induce immune‐related adverse events (irAEs). Cutaneous irAEs are notable for being the most common and for their early onset; however, the risk factors underlying their development and severity remain unclear. In this study, we retrospectively analyzed 1224 Japanese
Tomoya Watanabe, Kohei Yamakawa, Miyu Kobayashi, Yusuke Saigusa, Yukie Yamaguchi   +4 more
wiley   +1 more source

Dried Blood Spot: A Tool to Ensure Broad Access to Hepatitis D Screening, Diagnosis, and Treatment Monitoring. [PDF]

Liver Int
Matar R, Roudot-Thoraval F, Ortonne V, Garrigou O, Soulier A, Cappy P, Candotti D, Ingiliz P, Pawlotsky JM, Leroy V, Chevaliez S.   +10 more
europepmc   +1 more source